Frequency of overexpression of HER3 and prognostic consequences in European patients with early gastric cancer.

Nieves Martínez Lago,Ihab Abdulkader Nallib,Maria Vieito,Juan Jose Carrera,Sonia Candamio Folgar,Yolanda Vidal Insua,F. Rivera,José Ramón Antúnez López,Rafael Lopez,Maria-Elena Padín-Iruegas

Frequency of overexpression of HER3 and prognostic consequences in European patients with early gastric cancer.

2018

Nieves Martínez Lago
Ihab Abdulkader Nallib
Maria Vieito
Juan Jose Carrera
Sonia Candamio Folgar
Yolanda Vidal Insua
F. Rivera
José Ramón Antúnez López
Rafael Lopez
Maria-Elena Padín-Iruegas

4068Background: HER2 status is a predictive biomarker to response to trastuzumab in metastatic gastric adenocarcinomas. However, relatively little is known about the role of HER2 and HER3 in the no...

Keywords:

Pathology
Oncology
Internal medicine
Medicine
Early Gastric Cancer
predictive biomarker
Trastuzumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations